Related Experiment Videos
Tob-mediated cross-talk between MARCKS phosphorylation and ErbB-2 activation
1Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Taejon, 305-701, Republic of Korea.
Summary
Protein kinase C (PKC) activator PMA causes phosphorylation of MARCKS, increasing its binding to Tob. This interaction displaces Tob from ErbB-2, activating ErbB-2 signaling in breast cancer cells.
Area of Science:
- Biochemistry
- Cell Biology
- Cancer Research
Background:
- ErbB-2 signaling is crucial in human breast cancer.
- Protein kinase C (PKC) activators influence cancer cell pathways.
- Tob is a known anti-proliferative factor that interacts with ErbB-2.
Purpose of the Study:
- To investigate the biochemical pathway for ErbB-2 activation by PKC activators.
- To elucidate the role of myristoylated alanine-rich C kinase substrate (MARCKS) and Tob in this process.
Main Methods:
- Utilized MDA-MB-231 human breast cancer cells.
- Investigated protein phosphorylation using PKC activators (PMA).
- Assessed protein-protein interactions (MARCKS-Tob, Tob-ErbB-2) and their functional consequences.
Main Results:
- PMA treatment induced MARCKS phosphorylation, enhancing its binding to Tob.
- The phosphorylation site domain (PSD) of MARCKS is critical for Tob interaction.
- MARCKS phosphorylation led to decreased Tob binding to ErbB-2.
- This displacement resulted in the activation of ErbB-2 mediated signal transduction.
Conclusions:
- PKC-mediated MARCKS phosphorylation is a key mechanism for ErbB-2 activation.
- The MARCKS-Tob interaction modulates Tob's association with ErbB-2.
- This pathway represents a novel target for breast cancer therapy by modulating ErbB-2 signaling.